Latest revenue
—
as of —
Latest net income
—
as of —
Net margin
—
as of —
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $11.06B
- Enterprise value
- $11.06B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $17.40
- 52-wk low
- $3.41
- Beta
- —
- Shares out
- 809.4M
5-year trend
About KZIA
Business description and risk factors will appear here once KZIA's latest filing is fully ingested.
Earnings tracker
Not enough quarterly history for KZIA yet to draw an earnings tracker.
Industry trend
Pharmaceutical Preparations · SIC 2834
Your notes
Keep private notes on KZIA — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
No insider transactions on file for KZIA in the last 12 months.
Source: SEC Form 4 filings. Backfill runs nightly.
Who owns KZIA
Institutional value
$2.0M
Total shares held
280.9K
Distinct holders
8
-14 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | FLPUTNAM INVESTMENT MANAGEMENT CO | 142.5K | $1.1M | — | New |
| 2 | Sequoia Financial Advisors, LLC | 60.0K | $446.4K | — | New |
| 3 | Westside Investment Management, Inc. | 50.4K | $375.2K | +19.6K (+63.3%) | Added |
| 4 | UBS Group AG | 13.9K | $103.7K | +13.7K (+7119.7%) | Added |
| 5 | GAMMA Investing LLC | 1.6K | $11.7K | +1.3K (+575.9%) | Added |
| 6 | RHUMBLINE ADVISERS | 1.4K | $10.4K | -163 (-10.4%) | Trimmed |
| 7 | BNP PARIBAS FINANCIAL MARKETS | 1.1K | $8.0K | — | New |
| 8 | FNY Investment Advisers, LLC | 10.0K | $74 | +2.5K (+33.3%) | Added |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once KZIA's latest filing finishes processing.